Adverse events as potential predictive factors of activity in patients with advanced hepatocellular carcinoma treated with lenvatinib.

Rapposelli IG, Tada T, Shimose S, Burgio V, Kumada T, Iwamoto H, Hiraoka A, Niizeki T, Atsukawa M, Koga H, Hirooka M, Torimura T, Iavarone M, Tortora R, Campani C, Lonardi S, Tamburini E, Piscaglia F, Masi G, Cabibbo G, Giuseppe Foschi F, Silletta M, Tsuji K, Ishikawa T, Takaguchi K, Kariyama K, Itobayashi E, Tajiri K, Shimada N, Shibata H, Ochi H, Yasuda S, Toyoda H, Fukunishi S, Ohama H, Kawata K, Tani J, Nakamura S, Nouso K, Tsutsui A, Nagano T, Tanaka T, Itokawa N, Okubo T, Arai T, Imai M, Joko K, Koizumi Y, Hiasa Y, Rimini M, Ratti F, Aldrighetti L, Cascinu S, Casadei-Gardini A

Open source

DOI: 10.1111/liv.15014
Published: 2021 Dec
Container: Liver international : official journal of the International Association for the Study of the Liver
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/liv.15014,
  title = {Adverse events as potential predictive factors of activity in patients with advanced hepatocellular carcinoma treated with lenvatinib.},
  author = {Rapposelli IG and Tada T and Shimose S and Burgio V and Kumada T and Iwamoto H and Hiraoka A and Niizeki T and Atsukawa M and Koga H and Hirooka M and Torimura T and Iavarone M and Tortora R and Campani C and Lonardi S and Tamburini E and Piscaglia F and Masi G and Cabibbo G and Giuseppe Foschi F and Silletta M and Tsuji K and Ishikawa T and Takaguchi K and Kariyama K and Itobayashi E and Tajiri K and Shimada N and Shibata H and Ochi H and Yasuda S and Toyoda H and Fukunishi S and Ohama H and Kawata K and Tani J and Nakamura S and Nouso K and Tsutsui A and Nagano T and Tanaka T and Itokawa N and Okubo T and Arai T and Imai M and Joko K and Koizumi Y and Hiasa Y and Rimini M and Ratti F and Aldrighetti L and Cascinu S and Casadei-Gardini A},
  year = {2021},
  journal = {Liver international : official journal of the International Association for the Study of the Liver},
  doi = {10.1111/liv.15014},
  url = {https://doi.org/10.1111/liv.15014}
}

RIS

TY  - JOUR
TI  - Adverse events as potential predictive factors of activity in patients with advanced hepatocellular carcinoma treated with lenvatinib.
AU  - Rapposelli IG
AU  - Tada T
AU  - Shimose S
AU  - Burgio V
AU  - Kumada T
AU  - Iwamoto H
AU  - Hiraoka A
AU  - Niizeki T
AU  - Atsukawa M
AU  - Koga H
AU  - Hirooka M
AU  - Torimura T
AU  - Iavarone M
AU  - Tortora R
AU  - Campani C
AU  - Lonardi S
AU  - Tamburini E
AU  - Piscaglia F
AU  - Masi G
AU  - Cabibbo G
AU  - Giuseppe Foschi F
AU  - Silletta M
AU  - Tsuji K
AU  - Ishikawa T
AU  - Takaguchi K
AU  - Kariyama K
AU  - Itobayashi E
AU  - Tajiri K
AU  - Shimada N
AU  - Shibata H
AU  - Ochi H
AU  - Yasuda S
AU  - Toyoda H
AU  - Fukunishi S
AU  - Ohama H
AU  - Kawata K
AU  - Tani J
AU  - Nakamura S
AU  - Nouso K
AU  - Tsutsui A
AU  - Nagano T
AU  - Tanaka T
AU  - Itokawa N
AU  - Okubo T
AU  - Arai T
AU  - Imai M
AU  - Joko K
AU  - Koizumi Y
AU  - Hiasa Y
AU  - Rimini M
AU  - Ratti F
AU  - Aldrighetti L
AU  - Cascinu S
AU  - Casadei-Gardini A
PY  - 2021
JO  - Liver international : official journal of the International Association for the Study of the Liver
DO  - 10.1111/liv.15014
UR  - https://doi.org/10.1111/liv.15014
ER  -

APA

IG, R., T, T., S, S., V, B., T, K., H, I., A, H., T, N., M, A., H, K., M, H., T, T., M, I., R, T., C, C., S, L., E, T., F, P., G, M., G, C., F, G. F., M, S., K, T., T, I., K, T., K, K., E, I., K, T., N, S., H, S., H, O., S, Y., H, T., S, F., H, O., K, K., J, T., S, N., K, N., A, T., T, N., T, T., N, I., T, O., T, A., M, I., K, J., Y, K., Y, H., M, R., F, R., L, A., S, C., & A, C. (2021). Adverse events as potential predictive factors of activity in patients with advanced hepatocellular carcinoma treated with lenvatinib.. Liver international : official journal of the International Association for the Study of the Liver. https://doi.org/10.1111/liv.15014

Source records

pubmed · retrieved 2026-09-27T10:55:56.964Z
europe-pmc · retrieved 2026-09-27T10:55:56.970Z